MXCT
Price:
$4.11
Market Cap:
$433.53M
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electropora...[Read more]
Industry
Medical - Devices
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
MXCT
According to MaxCyte, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.81. This represents a change of -18.28% compared to the average of 12.01 of the last 4 quarters.
The mean historical Current Ratio of MaxCyte, Inc. over the last ten years is 6.39. The current 9.81 Current Ratio has changed 15.26% with respect to the historical average. Over the past ten years (40 quarters), MXCT's Current Ratio was at its highest in in the September 2021 quarter at 21.43. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
6.39
Median
3.66
Minimum
1.22
Maximum
17.32
Discovering the peaks and valleys of MaxCyte, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 344.41%
Maximum Annual Current Ratio = 17.32
Minimum Annual Increase = -34.86%
Minimum Annual Current Ratio = 1.22
Year | Current Ratio | Change |
---|---|---|
2023 | 10.65 | -34.86% |
2022 | 16.35 | -5.56% |
2021 | 17.32 | 344.41% |
2020 | 3.90 | 48.88% |
2019 | 2.62 | -23.38% |
2018 | 3.42 | -19.05% |
2017 | 4.22 | 51.03% |
2016 | 2.79 | 129.65% |
2015 | 1.22 | -13.63% |
2014 | 1.41 | 141.76% |
The current Current Ratio of MaxCyte, Inc. (MXCT) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
14.77
5-year avg
10.17
10-year avg
6.39
MaxCyte, Inc.’s Current Ratio is less than Sight Sciences, Inc. (10.18), less than CVRx, Inc. (11.32), greater than NeuroPace, Inc. (5.59), greater than Rapid Micro Biosystems, Inc. (5.52), greater than CONMED Corporation (2.27), greater than OrthoPediatrics Corp. (7.17), greater than Surmodics, Inc. (3.96), greater than Integer Holdings Corporation (3.28), greater than Pulmonx Corporation (7.70), greater than IRadimed Corporation (9.21), greater than Orthofix Medical Inc. (2.39), greater than ProSomnus, Inc. (0.30), greater than Anika Therapeutics, Inc. (5.34), greater than Heska Corporation (6.70),
Company | Current Ratio | Market cap |
---|---|---|
10.18 | $180.18M | |
11.32 | $313.00M | |
5.59 | $332.51M | |
5.52 | $40.28M | |
2.27 | $2.16B | |
7.17 | $546.67M | |
3.96 | $567.19M | |
3.28 | $4.52B | |
7.70 | $243.25M | |
9.21 | $687.03M | |
2.39 | $662.63M | |
0.30 | $8.18M | |
5.34 | $239.16M | |
6.70 | $1.31B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MaxCyte, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MaxCyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is MaxCyte, Inc.'s Current Ratio?
How is the Current Ratio calculated for MaxCyte, Inc. (MXCT)?
What is the highest Current Ratio for MaxCyte, Inc. (MXCT)?
What is the 3-year average Current Ratio for MaxCyte, Inc. (MXCT)?
What is the 5-year average Current Ratio for MaxCyte, Inc. (MXCT)?
How does the current Current Ratio for MaxCyte, Inc. (MXCT) compare to its historical average?